Table 1:
Baseline characteristics of the study groups
| TA-TAVI (n = 27) | AVR (n = 37) | P-value | |
|---|---|---|---|
| Age (years) | 82.2 ± 4.7 | 67.5 ± 8.9 | <0.001 |
| Female gender | 20 (74.1) | 18 (48.6) | 0.04 |
| Logistic EuroSCORE (%) | 36.4 ± 13.2 | 2.6 ± 8.5 | <0.001 |
| Arterial hypertension | 27 (100) | 28 (75.6) | 0.01 |
| Diabetes mellitus | 8 (29.6) | 3 (8.1) | 0.03 |
| Hyperlipidaemia | 20 (74.1) | 22 (59.4) | 0.17 |
| Smoking | 8 (29.6) | 19 (51.3) | <0.05 |
| Coronary artery disease | 15 (55.5) | 0 | <0.001 |
| Previous cardiac surgery | 4 (14.8) | 0 | 0.03 |
| Ejection fraction (%) | 55.3 ± 8.9 | 60.3 ± 14.4 | 0.12 |
| Peripheral vascular disease | 8 (29.6) | 1 (2.7) | 0.01 |
| Previous cerebral ischaemic event | 6 (22.2) | 0 | 0.01 |
| Porcelain aorta | 1 (3.7) | 0 | 0.42 |
| Educational level (years at school >8) | 4 (14.8) | 12 (32.4) | 0.07 |
Continuous variables are presented as means ± SD and categorical variables as frequencies (percentage).
AVR: aortic valve replacement; TA-TAVI: transapical transcatheter aortic valve implantation.